Boston Scientific and Blackstone Announce $455M Heart Pump Development Deal
The companies will co-fund development of the VITALYST temporary heart pump for cardiogenic shock.
Boston Scientific Corporation and Blackstone Life Sciences announced a $455M collaboration to co-fund development of the VITALYST temporary heart pump for cardiogenic shock. No prior-period comparison was provided.Material DetailsContext by AI AnalystThis is an early-stage product-development updat…